过去一年中添加的文章,按日期排序

[HTML][HTML] Navigating Complexities: Leadless Pacemaker Management in Proton Therapy for a Pacemaker-Dependent Bilateral Breast Cancer Patient

M Saki, H Grewal, M Artz, TR Willoughby, J Park… - … of Particle Therapy, 2024 - Elsevier
1 天前 - … Following Micra implantation, the patient underwent the proton treatment without …
therapy for individuals with leadless cardiac devices and novel solutions to navigate cardiac

Central Venous Catheter-related Right Atrial Thrombus in oncology patients: A Case Series of Cardiovascular Magnetic Resonance Studies

I Cardoso, J de Almeida, Z Tsoumani… - European Heart …, 2024 - academic.oup.com
1 天前 - Background Patients with cancer are at increased risk of thrombus formation, often
identified on routine echocardiogram in the right atrium. The 2022 ESC Guidelines on Cardio…

… on Nuclear Factor Erythroid 2-related Factor 2 (NRF2) and Kelch-like ECH-associated Protein 1 (KEAP1) Gene Expression in Mice with Acute Cadmium Poisoning

T Tao, X Li, L Li - Alternative therapies in health and medicine - pubmed.ncbi.nlm.nih.gov
1 天前 - … Tea polyphenols extracted from green tea have wide biological properties, including
anti-cardiovascular disease, anti-tumor, anti-inflammatory, and immune regulation. The …

Glucagon-Like Peptide 1 Receptor Agonists: A Role in Glaucoma?

C Johnson, LR Pasquale… - Ophthalmology … - ophthalmologyglaucoma.org
1 天前 - disease and Parkinson’s disease, and are considered as potential therapy for a wide
variety of neurologic diseases … research for diabetes, cardiac disease, and weight loss, as …

Assessment of cardiotoxicity in cancer patients on chemotherapy in a low resource setting: is echocardiography the ultimate tool, or should we look for another?

RC Anakwue, AM Anakwue… - Annals of Clinical and …, 2024 - africa.pagepress.net
1 天前 - anticancer therapies cause cardiovascular dysfunction and may deny patients with
cancer the life-saving benefits of chemotherapy … resonance in cardiovascular disease. Task …

Unveiling Vascular Masquerades: A Case of Iliac Internal Stenosis Mimicking GTPS.

M Håmsø - International Journal of Sports Physical Therapy, 2024 - search.ebscohost.com
1 天前 - … , including a battle with breast cancer, cardiovascular problems, and gastrointestinal
… symptoms, especially those with underlying cardiovascular risk factors. It highlights the …

[HTML][HTML] Pitavastatin sensitizes the EGFR-TKI associated resistance in lung cancer by inhibiting YAP/AKT/BAD-BCL-2 pathway

J Liu, J Fu, P Fu, M Liu, Z Liu, B Song - Cancer Cell International, 2024 - Springer
1 天前 - … the main mechanisms of tumor drug resistance. A … cardiovascular diseases.
Previous studies have also documented its ability to improve the therapeutic impact in lung cancer

[PDF][PDF] Assessing Utilization of Services by the Patients receiving Benefits under “Sahara Scheme” in a District of Himachal Pradesh (HP): A Retrospective Data …

S Kumar, S Kanwal, N Pawar - Cancer - researchgate.net
1 天前 - Cancer was the most common morbidity for which the patients received the financial
assistance followed by chronic kidney disease and cardiovascular diseases. There is a …

KidsTUMove—A Holistic Program for Children with Chronic Diseases, Increasing Physical Activity and Mental Health

N Stöcker, D Gaser, R Oberhoffer-Fritz… - Journal of Clinical …, 2024 - mdpi.com
1 天前 - … the quality of life for children with congenital heart diseases (CHD). Following the
Heart Center Munich, the offerings have expanded since 2011 to include childhood cancer

Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when

AD Anastasilakis, MP Yavropoulou… - European Journal of …, 2024 - academic.oup.com
1 天前 - … Denosumab or romosozumab therapy 1 and risk of cardiovascular events in
patients with primary osteoporosis: Systematic review 2 and meta- analysis. Bone 2020 130 …